Cellipont Bioservices and Adva Biotechnology Unveil ADVA X3 Platform
Cellipont Bioservices has joined hands with Adva Biotechnology, marking the launch of the groundbreaking ADVA X3 platform in North America.
Cellipont Bioservices | 09/05/2024 | By Aishwarya | 255
Cellipont Bioservices announces strategic debt facility investment from OrbiMed
The 76,000 sq foot facility will feature significant capabilities including process and analytical development and manufacturing services for CAR-T, IPSC, MSC and other types of cell therapies
Cellipont Bioservices | 22/03/2023 | By Sudeep Soparkar | 287
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy